KeyVex › Disclosures › Congressional trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Dwight Evans (House) disclosed 9 transactions

· Congressional trades · U.S. Senate Electronic Financial Disclosure / U.S. House Clerk

Amendment status is not available for House filings. A filing listed here may since have been amended.

2022-03-30 · sellTwist Bioscience Corporation — $1,001 - $15,000
2022-03-30 · sellNeoGenomics, Inc. — $1,001 - $15,000
2022-03-30 · buyKinder Morgan, Inc. — $1,001 - $15,000
2022-03-30 · buyIntel Corporation — $1,001 - $15,000
2022-03-30 · buyGeneral Dynamics Corporation — $1,001 - $15,000
2022-03-30 · sellCelanese Corporation Celanese Corporation — $1,001 - $15,000
2022-03-30 · sellARK Innovation ETF — $1,001 - $15,000
2022-03-25 · sellARK Genomic Revolution ETF — $1,001 - $15,000
2022-03-25 · sellARK Genomic Revolution ETF — $1,001 - $15,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

ownerSelf
partyDemocrat
statePA
officeEvans, Dwight (Representative)
ptr id20020865
chamberhouse
comment—
amount max15000
amount min1001
asset typeST
report urlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/20020865.pdf
bioguide idE000296
data sourceHOUSE_CLERK_PTR
member lastEvans
member nameDwight Evans
amount range$1,001 - $15,000
member firstDwight
state districtPA03
disclosure date2022-04-25
transaction natureOPEN_MARKET

Each transaction (9)

idtickerasset nametransaction datetransaction typereporting lag days
house-20020865-9TWSTTwist Bioscience Corporation2022-03-30sell19
house-20020865-8NEONeoGenomics, Inc.2022-03-30sell19
house-20020865-7KMIKinder Morgan, Inc.2022-03-30buy19
house-20020865-6INTCIntel Corporation2022-03-30buy19
house-20020865-5GDGeneral Dynamics Corporation2022-03-30buy19
house-20020865-4CECelanese Corporation Celanese Corporation2022-03-30sell19
house-20020865-3ARKKARK Innovation ETF2022-03-30sell19
house-20020865-2ARKGARK Genomic Revolution ETF2022-03-25sell22
house-20020865-1ARKGARK Genomic Revolution ETF2022-03-25sell22

Original filing document